What BIO Protocol does

BIO Protocol, operated by the Swiss-domiciled BIO.XYZ Association in Zug, is a decentralized science (DeSci) platform built primarily on Ethereum with Solana expansion, that provides financial infrastructure for early-stage biotechnology research through Biotech Decentralized Autonomous Organizations (BioDAOs) and tokenized intellectual property. The platform enables researchers to raise funds directly from global communities of patients, researchers, and crypto users, bypassing traditional grant gatekeepers and venture capital, while creating on-chain governance for research prioritization and commercialization. Core technology components include the Launchpad V2 (fixed-price token sale mechanism), BioXP (a non-transferable point system determining allocation priority in oversubscribed sales), veBIO (a 52-week vote-escrowed governance mechanism), and BioAgents — autonomous AI-powered scientific agents including Aubrai (built with VitaDAO for longevity) and BIO Copilot for hypothesis generation and research acceleration.

The product portfolio spans core protocol infrastructure (Launchpad V2, Dashboard, Portfolio), AI modules (BioAgents at ai.bio.xyz, OpenLabs launched June 2026), collaborative research platforms (Science Beach with Molecule, launched March 2026), and the BIO token (max supply 3.32 billion, TGE January 2025, Coinbase-listed July 2025). The ecosystem comprises 11 vertical BioDAOs spanning longevity, brain health, hair loss, psychedelics, reproductive health, cryopreservation, synthetic biology, long COVID, quantum biology, and rare disease. Revenue is generated through a 1% trading fee on secondary BIO/Token liquidity pool transactions (30% retained by Bio.xyz) and a 2% launchpad fee on token launches; the platform does not charge for AI agent services directly. Distribution is non-custodial and self-serve through web interfaces (app.bio.xyz, ai.bio.xyz, gov.bio.xyz) and MetaMask-compatible wallets, with no sales force. The company is privately held, has 11-50 employees, and has raised $33M+ via the BIO Genesis initiative plus a disclosed $6.9M round in September 2025 led by Maelstrom, with prior backing from YZi Labs (formerly Binance Labs), Animoca Brands, and a $1M personal investment from Arthur Hayes.

Notable enterprise validation came via a November 2025 partnership with Pfizer for IP tokenization, and a concrete AI-driven discovery output — OX2R-004, an AI-generated peptide agonist for ADHD — was announced in April 2026. The platform restricts service in 29 jurisdictions including the United States and United Kingdom, which constrains the addressable retail market but does not limit the institutional and non-restricted-region user base.

Name

BIO Protocol

Legal name

BIO.XYZ Association

Website

https://bio.xyz

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

BIO Protocol is a decentralized science (DeSci) platform on Ethereum and Solana that enables patient, researcher, and crypto communities to fund and govern early-stage biotech research through BioDAOs and tokenized IP. It serves 11 vertical BioDAOs, integrates AI co-scientist agents, and monetizes via launchpad and trading fees.

Ownership category

akta.pro rank

Product category

Decentralized Science Platform

NAICS

Computer Systems Design and Related Services (54151), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Finance Services (6199), Security & Commodity Brokers, Dealers, Exchanges & Services (6200), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Launchpads, IDOs & Token Distribution via DEXs (FSADABAL)

akta.pro secondary industries

Consortium Networks & Governance (network setup, onboarding, rules, node operations) (FSAPAIAB), RWA Settlement, Transfer Agent & Lifecycle Management Infrastructure (FSADAEAN)

Keywords

• Decentralized science
• Biotech funding platform
• DAO infrastructure
• IP tokenization
• AI drug discovery

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Trading Fees: A 1% trading fee is applied automatically to all secondary market trades executed within the primary BIO/Token Liquidity Pool. Of collected fees, 70% is allocated to the Project's designated treasury wallet and 30% to Bio.xyz.
2. Launchpad Fees: Bio Protocol charges a 2% fee on token launches conducted via the Launchpad V2, with 2% allocated to Bio.xyz as the standard launching fee.
3. Staking Rewards: Users can stake BIO tokens and ecosystem tokens to earn BioXP points, with staking mechanisms providing access to platform features and token launches that require an active staking position.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Core offering

BIO Protocol operates a decentralized science (DeSci) platform that provides a financial layer for funding and developing early-stage biotech research through tokenized intellectual property and Biotech Decentralized Autonomous Organizations (BioDAOs). The platform enables permissionless token launches via Launchpad V2, allocates participation priority through the BioXP point system, and supports AI-driven hypothesis generation through BioAgents including Aubrai (built with VitaDAO) and BIO Copilot. The protocol is deployed on Ethereum and Solana, governed by veBIO token holders, and generates revenue through trading and launchpad fees.

Product overview

BIO Protocol is a decentralized science (DeSci) platform built on Ethereum and Solana that enables global communities of patients, researchers, and crypto users to fund and develop early-stage biotech through Biotech Decentralized Autonomous Organizations (BioDAOs). The platform's core product is the Bio Protocol infrastructure supporting multiple interconnected modules: Launchpad V2 (fixed-price token launch mechanism with BioXP point system and staking mechanisms), BioAgents (network of AI-powered scientific agents including Aubrai and BIO Copilot for hypothesis generation and research acceleration), Dashboard and Portfolio tools for ecosystem analytics, and the BIO token with veBIO governance mechanism. Additional offerings include OpenLabs (AI research hub for community funding), Science Beach (human-AI collaborative research platform), and the BIO Genesis initiative. The ecosystem encompasses 11 BioDAO projects focused on longevity, rare diseases, synthetic biology, brain health, hair loss, psychedelic research, cryopreservation, and quantum biology.

Differentiator

Problem solved

Functional benefit

Brands

• BioXP: BioXP is a point system within the Bio Protocol V2 platform used to determine allocation priority in token launches. Users accrue BioXP through staking BIO, staking ecosystem tokens, participating in token launches, and social engagement activities.
• BioAgents
• BioDAOs
• OpenLabs
• Science Beach

Products and services

• Bio Protocol Core Platform Decentralized science (DeSci) platform built on Ethereum and Solana enabling community-driven funding and governance of biotechnology research through Biotech Decentralized Autonomous Organizations (BioDAOs). Functions as financial infrastructure for biotech innovation using tokenized intellectual property and on-chain governance, used by researchers, patients, and crypto users globally.
• Launchpad V2 Permissionless token launch platform featuring the Fixed Price Sale Launcher for curated fixed-price sales of newly issued tokens in exchange for BIO, the BioXP Point System for allocation priority, and staking mechanisms for BIO and ecosystem tokens. Used by researchers and BioDAOs to launch tokenized IP assets and raise funds from the BIO community.
• BioAgents Network of AI-powered scientific agents enabling hypothesis generation, funding coordination, and commercialization of biotech discoveries. Named agents include Aubrai (built with VitaDAO for longevity research) and BIO Copilot for research acceleration. Used by researchers and patients to access AI co-scientist capabilities for biotech research.
• OpenLabs AI research hub combining AI-assisted research development, community funding, and on-chain governance as an alternative to traditional grant-based research financing. Enables researchers to seek funding through community voting by BIO token holders, with flagship projects RheumaAI (autoimmune disease research) and PeptAI (peptide-based AI drug discovery).
• Science Beach Open scientific public domain enabling collaboration between AI agents and humans on scientific hypotheses from initial ideas through IP funding. Launched with Molecule on Solana, the platform uses the BIOS economic coordination layer for research fee payments and result storage. Generated over 1,100 hypotheses with 59 AI agents and 55 users.
• Dashboard Ecosystem analytics platform to track performance and key metrics of projects across the Bio ecosystem. Used by community members, researchers, and investors to monitor BioDAO projects, token performance, and platform statistics.
• Portfolio User portfolio tracking interface within the Bio app ecosystem, allowing individual users to monitor their token holdings, BioXP points, veBIO positions, and Launchpad allocations.
• BIO Genesis Initial genesis event and funding initiative for Bio Protocol that has raised over $33 million to support decentralized science projects through tokenized intellectual property and decentralized autonomous organization mechanisms.

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability7 records

Feature5 records

Partnerships

13 partnerships are on record, tiered core and minor.

• Molecule (on Solana)coreStrategic or Co-development Partner · 6 March 2026Launched Science Beach, an open scientific public domain enabling AI-human collaboration on scientific hypotheses. Molecule deploys an autonomous agent for research fee payments and result storage while Bio Protocol provides the BIOS economic coordination layer.
• PfizercoreStrategic or Co-development Partner · 26 August 2025Bio Protocol partnered with Pfizer on intellectual property tokenization for drug development, representing a significant validation of the DeSci model by a major pharmaceutical company.
• VitaDAOcoreStrategic or Co-development Partner · 23 August 2025VitaDAO partnered with Bio Protocol to build the AI-powered science agent Aubrai, combining longevity science expertise with AI-driven research capabilities.
• HairDAOcoreOthersBioDAO focused on hair loss research operating within the Bio Protocol ecosystem with token (HAIR) launched via Launchpad.
• PsyDAOcoreOthersBioDAO focused on psychedelic research operating within the Bio Protocol ecosystem with token (PSY) launched via Launchpad.
• CerebrumDAOcoreOthersBioDAO focused on brain health that approved funding for a human clinical trial for a brain health supplement. Token (NEURON) launched via Launchpad.
• AthenaDAOcoreOthersBioDAO focused on reproductive health research operating within the Bio Protocol ecosystem with token (ATH) launched via Launchpad.
• CryoDAOcoreOthersBioDAO focused on cryopreservation research operating within the Bio Protocol ecosystem with token (CRYO) launched via Launchpad.
• ValleyDAOcoreOthersBioDAO focused on synthetic biology operating within the Bio Protocol ecosystem with token (GROW) launched via Launchpad.
• Long COVID LabscoreOthersBioDAO focused on Long COVID research operating within the Bio Protocol ecosystem with token (COVID) launched via Launchpad.
• Quantum Biology DAOcoreOthersBioDAO focused on quantum biology research operating within the Bio Protocol ecosystem with token (QBIO) launched via Launchpad.
• ResearchHubcoreOthersResearchHub is a partner BioDAO within the ecosystem focused on general scientific research funding and collaboration.
• CuretopiaminorOthersBioDAO partner within the ecosystem focused on developing cures for various conditions.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Molecule: Molecule is a decentralized science (DeSci) platform for tokenizing biotech intellectual property via IP-NFTs, directly comparable to BIO Protocol's IP-token model. They are simultaneously a partner (Science Beach) and a direct competitor in DeSci IP tokenization infrastructure.
• VitaDAO: VitaDAO is the leading longevity-focused BioDAO and a core BIO Protocol ecosystem member that partnered on the AI agent Aubrai. It is directly comparable as a token-governed research funding DAO and one of BIO's flagship launchpad graduates.
• ResearchHub: ResearchHub is a partner BioDAO within BIO Protocol's ecosystem focused on general scientific research funding and collaboration, comparable as a community-driven, token-incentivized research platform overlapping BIO's DeScientists value proposition.
• DAO Maker: DAO Maker is a leading crypto launchpad and token offering platform with strong fee-based revenue from IDOs. Directly comparable to BIO Protocol's Launchpad V2 mechanics (fixed-price sales, allocation tiers, staking for priority).
• Polkastarter: Polkastarter is a multi-chain decentralized launchpad enabling permissionless token pools and fixed-weight swaps. Comparable to BIO Protocol's Launchpad V2 in mechanism (fixed-price token sales, DEX-based liquidity) and target audience (early-stage crypto projects).
• Seedify: Seedify is a crypto launchpad and incubator with tiered staking and IDO mechanics. Comparable to BIO Protocol in its launchpad-as-a-service model, staking-based allocation priority (analogous to BioXP), and fee revenue from token launches.
• CerebrumDAO: CerebrumDAO is a brain-health-focused BioDAO operating within BIO Protocol's ecosystem, with its own NEURON token launched via the Launchpad. Directly comparable as a vertical-specialized research DAO and a representative unit of BIO's 11-BioDAO network.

Broad incumbents

• Ocean Protocol: Ocean Protocol is an established decentralized data exchange for tokenizing datasets and data services. Comparable as a broader Web3 incumbent pursuing the tokenization of intangible assets (data vs. IP), though focused on data rather than biotech IP specifically.
• SingularityNET: SingularityNET is a decentralized AI services marketplace built on blockchain, with token-incentivized AI agent commerce. Comparable to BIO Protocol's BioAgents network as a blockchain-based marketplace for AI services, with overlap in the AI-agent monetization model.

Emerging players

• Story Protocol: Story Protocol is a Layer-1 blockchain purpose-built for tokenizing intellectual property across creative and technical domains. Comparable as an emerging player in IP tokenization with adjacent scope to BIO Protocol's biotech-specific IP-token model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/bioprotocol
• YouTubeyoutube.com/@thebioprotocol

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries11 records

Funding overview

Funding rounds2 records

Investors21 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIO Protocol